USPTO serial 99302309
CC
Reviewed by CopyMark Law Group
Status 688Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- LEE, SANG MIN
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with CC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*
Plus Government fees of $150
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
CY BATES
CY BATES CP LAW GROUP PCP.O. BOX 5195OCEANSIDE, CA 92052UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical cleansers for skin and wounds; Liquid bandages for skin wounds; Pharmaceutical preparations for skin wounds; Bandages for skin wounds; Pharmaceutical preparations for wounds; Biological preparations for the treatment of musculoskeletal and orthopedic conditions including osteoarthritis, tendon and ligament injuries, fractures and non-unions, bulging or herniated discs, degenerative disc disease, carpal tunnel syndrome, cartilage injuries, muscle injuries, temporomandibular joint (TMJ) disorder, piriformis syndrome, sciatica, sacroiliac (SI) joint dysfunction, and osteonecrosis; Biological preparations for the treatment of autoimmune and inflammatory conditions including multiple sclerosis (MS), Crohn’s disease, and rheumatoid arthritis; Biological preparations for the treatment of neurological conditions including stroke, dementia, Parkinson’s disease, Huntington’s disease, spinal cord injury, post-concussion syndrome, and autism spectrum disorder; Biological preparations for the treatment of cardiovascular diseases including heart failure, peripheral artery disease, ischemic heart disease, and general cardiovascular disease; Biological preparations for the treatment of metabolic diseases including Type 1 and Type 2 diabetes, and obesity; Biological preparations for the treatment of hematological and immune diseases including, leukemia, lymphoma, myeloma, myelodysplastic syndrome, and myeloproliferative disorders; Biological preparations for the treatment of ophthalmologic conditions including macular degeneration, retinal detachment, and macular hole; Biological preparations for the treatment of liver and gastrointestinal diseases including chronic liver diseases, cirrhosis, liver failure, and Inflammatory bowel disease; Biological preparations for the treatment of chronic pain and degenerative conditions including fibromyalgia, chronic joint pain, and chronic wounds or non-healing ulcers | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 13, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 1, 2026 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Sep 1, 2026 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Sep 1, 2026 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Jul 27, 2026 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Jul 27, 2026 | APET | ASSIGNED TO PETITION STAFF | — |
| Jul 13, 2026 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Jul 13, 2026 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Jun 16, 2026 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Feb 4, 2026 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jan 13, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 13, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 7, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 12, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 11, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 5, 2025 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Dec 5, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 25, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 25, 2025 | NWAP | NEW APPLICATION ENTERED | — |